Previous years
2023
6/20/2023 Current Donor Selection Strategies for Allogeneic Hematopoietic Cell Transplantation – presented by Olga Timofeeva, PhD, MedStar Georgetown University Hospital, Washington, DC
7/18/2023 Molecular Biology Basics for the HLA Technologist – presented by Carolyn Hurley, PhD, Professor Emeritus, Georgetown University, Washington, DC
8/15/2023 Virtual and Reality: A Close Look at the UCLA Virtual Crossmatch Exchange Results - presented by Jennifer Q. Zhang, PhD, UCLA Immunogenetics Center, David Geffen School of Medicine at UCLA, Los Angeles, CA
8/22/2023 HLA Loss Relapse in HCT Recipients: Insights from Immunobiology – presented by Esteban Arrieta-Bolanos, PhD, University Hospital Essen-Institute for Experimental Cellular Therapy, Essen, Germany
8/29/2023 Reducing Serum Background in Solid Phase Antibody Assays – presented by Maneesh Misra, PhD, University of Chicago Medicine, Chicago, IL
9/12/2023 The Role of Duffy Blood Group Antigens in Renal Transplant and Rejection - presented by Reut Hod Dvorai, PhD, SUNY Upstate Medical University, Syracuse, NY
10/3/2023 HCT Donor Selection: To Match or Mismatch – presented by Maria Bettinotti, PhD, Johns Hopkins University, Baltimore, MD
10/10/2023 Overcoming the Prozone Effect in Solid Phase Antibody Assays - presented by Maneesh Misra, PhD, University of Chicago Medicine, Chicago, IL
10/24/2023 HLA Antibody Analysis: Back to the Basics – presented by Julie Houp, CHS (ACHI), University of Alabama at Birmingham, Birmingham, AL
10/31/2023 Acute GVHD in a Solid Organ Transplant Patient in the Absence of Peripheral Blood Chimerism – presented by Peter Lalli, PhD, Carolinas Health System, Huntersville, NC
11/7/2023 DQA5-DQB2: Is it Me? or is it You! - presented by Jeffrey Kiernan, PhD, Regional Histocompatibility Laboratory University Health Networks, Toronto, ON, Canada
11/21/2023 Modeling HLA Antigenicity to Inform Virtual Crossmatch – presented by Loren Gragert, PhD, Tulane University School of Medicine, New Orleans, LA
11/28/2023 The HLA Laboratory’s Role in Supporting Platelet Transfusion Refractory Patients – presented by Dong Li, MD, MedStar Georgetown University Hospital, Washington, DC
12/5/2023 Laboratory Methods for the Detection of HLA Loss in Hematopoietic Cell Transplant Recipients – presented by Paula Arnold, PhD, St. Jude Children's Research Hospital, Memphis, TN
12/12/2023 Allele-Specific Solvent-Accessible Amino Acid Mismatches Are Correlated with Immunizer-Specific HLA Antibodies After Kidney Transplantation or Pregnancy – presented by Matthias Niemann, MS, PIRCHE AG, Berlin, Germany
1/9/2024 Calculating Epitope Immunogenicity Through De Novo Donor-Specific Antibody Targets in Renal Transplantation – presented by Jenny Tran, PhD, University of British Columbia, Vancouver, BC, Canada
1/23/2024 The Case of the Deceased Donor with Too Many HLA Alleles – presented by Matthew Cusick, PhD, University of Michigan Medicine, Ann Arbor, MI
1/30/2024 Imputation of Complete High Resolution HLA Types Using HaploStats – presented by Abeer Madbouly, PhD, and
Martin Maiers, MS, Bioinformatics Research, National Marrow Donor Program, Minneapolis, MN
2/6/2024 Characterization of Donor Specific Antibodies Following Solid Organ Transplant – presented by Matthew Najor, PhD, University of Michigan Medicine, Ann Arbor, MI
2/13/2024 DRB1 Dominance in the Immunopeptidome of Activated Macrophages - presented by Hooman Yari, PhD, University of Oklahoma Health Sciences Center, Oklahoma City, OK
2022
5/24/2022 Rapid High Resolution HLA Typing – presented by Eric Weimer, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
6/21/2022 The Immunopeptidome of Secondary DR Molecules – presented by Saghar Kaabinejadian, PharmD, PhD, Pure MHC, LLC, Austin, TX
7/19/2022 Histocompatibility Testing for the Novice – presented by Sandra Rosen-Bronson, PhD, MedStar Georgetown University Hospital, Washington, DC
7/26/2022 Engineering Artificial Antigen Presenting Cells – presented by Jonathan Schneck, MD, PhD, Johns Hopkins School of Medicine, Baltimore, MD
8/2/2022 Diversity, Equity, and Access to Transplant – presented by Edgar Milford, MD, Brigham and Women's Hospital, Boston, MA
8/9/2022 Acute GVHD in Solid Organ Transplant – presented by Caroline Alquist, MD, PhD, University of Cincinnati Hoxworth Blood Center, Cincinnati, OH
8/23/2022 Improved Immunological Risk Stratification of Pediatric Heart Transplant Patients by Combining PIRCHE-II with HLAMatchmaker or HLA-EMMA – presented by Massimo Mangiola, PhD, Transplant Institute, NYU Langone, New York, NY
8/30/2022 HLA Matching for Hematopoietic Cell Transplant: An Evolving Paradigm – presented by Stephen Spellman, MBS, CIBMTR Immunobiology and Observational Research NMDP/Be The Match Campus, Minneapolis, MN
9/13/2022 Continuous Distribution Kidney Allocation – presented by Cathi Murphy Half, PhD, Southwest Immunodiagnostics, Inc, San Antonio, TX, Peter Lalli, PhD, Carolinas Health System, Huntersville, NC, and John Lunz, PhD, LifeLink Transplant Immunology Laboratory, Tampa, FL
9/20/2022 Virtual Serology: A Strategy for Converting HLA Alleles to Serotypes – presented by Marcelo Fernandez-Vina, PhD, Stanford University School of Medicine, Palo Alto, CA
9/27/2022 Transfusion Medicine and Histocompatibility Laboratory Cooperation: The Case of the Surprise Post-Transplant ABO Titer – presented by Anne Halpin, MSc, CHS, University of Alberta Hospital, Edmonton, AB, Canada
10/11/2022 HLA-Haploidentical Transplantation: The Luxury of Selecting for HLA-Mismatch – presented by Shannon McCurdy, MD, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
10/18/2022 Characterization of Permissible HLA Allele Mismatches from Unrelated Hematopoietic Cell Transplant Cohorts – presented by Marcelo Fernandez-Vina, PhD, Stanford University School of Medicine, Palo Alto, CA
11/1/2022 Correlation of T- and B-Cell Epitope Mismatches with De Novo Donor-Specific Antibody Formation in Renal Transplant Recipients – presented by Elaine Chou-Wu, PhD, Immunogenetics/HLA, Bloodworks NW, Seattle, WA
11/8/2022 Epitope Matching and Eplet Analysis: A New Addition to the HLA Toolbox – presented by Ahmed Mostafa, MD, PhD, Saskatchewan Health Authority - St. Paul's Hospital, Saskatoon, SK, Canada
11/22/2022 Engraftment/Chimerism Monitoring: Fantasy to Reality – presented by Ahmed Mostafa, MD, PhD, Saskatchewan Health Authority-St. Paul's Hospital, Saskatoon, SK, Canada
11/29/2022 Evaluation of Interference from Therapeutic Antibodies on the Flow Cytometry Crossmatch Test – presented by Eszter Lazar-Molnar, PhD, University of Utah School of Medicine, Salt Lake City, UT
12/6/2022 The Consequences of HLA-DQ Mismatches in Kidney Transplantation – presented by Anat Tambur, DMD, PhD, Northwestern University, Chicago, IL
12/13/2022 A Unified ABO-Adjusted CPRA Metric May Improve Equity in Kidney Allocation – presented by James Lan, MD, Vancouver General Hospital Gordon & Leslie Diamond Health Care Center, Vancouver, BC, Canada
12/20/2022 Revised CPRA Metrics – presented by Loren Gragert, PhD, Tulane University School of Medicine, New Orleans, LA
2021
5/25/2021 Good Pipetting Practices – presented by Sandra Jabre, BS and Chris Phaneuf, BS, Mettler-Toledo Rainin, LLC, Oakland, CA
6/15/2021 The Kidney for Life Initiative – presented by Michael Cecka, PhD, University of California Los Angeles, Los Angeles, CA and Matthew Ronin, BS, National Kidney Registry, Babylon, NY
6/22/2021 Vaccine Development in the COVID-19 Era – presented by Todd Hatchette, MD, Division of Microbiology, Department of Pathology and Laboratory Medicine, Dalhousie University, Halifax, NS, Canada
7/13/2021 Virtual Crossmatch: One Size Doesn’t Fit All – presented by David Pinelli, PhD, Northwestern University Feinberg School of Medicine, Chicago, IL
7/20/2021 Hybrid Capture Technology: Next Generation HLA Typing and Beyond – presented by Carla M. Wirtz, CHS, CareDx, Inc., San Francisco, CA
7/27/2021 Next Generation Nanopore Sequence – presented by Karen Sherwood, PhD, University of British Columbia, Vancouver, BC, Canada
8/3/2021 Non-HLA Antibody Testing – presented by Michelle Hickey, PhD, UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, Los Angeles, CA
8/24/2021 The HLA Laboratory Experience with HLA-DSA – presented by Kelly Hitchman, PhD, University of Texas Health San Antonio, San Antonio, TX
8/31/2021 Optimizing NGS Workflow: Ensuring Quality Results from Every Run – presented by Anh Huynh, BA, CHS, HLA Technical Consultant, Transplant Diagnostics, Thermo Fisher Scientific, Los Angeles, CA
9/14/2021 Broadening Metrics for Immune Compatibility to Improve Equity in Organ Allocation – presented by Loren Gragert, PhD, Tulane University School of Medicine, New Orleans, LA and James Lan, MD, University of British Columbia, Department of Pathology and Laboratory Medicine and the Division of Nephrology, Vancouver, BC, Canada
9/21/2021 The impact of the COVID-19 Pandemic on Transplant Patients – presented by Robin Avery, MD, Johns Hopkins University, Baltimore, MD
10/5/2021 HLA as a Target of T Cell Tolerance – presented by Megan Levings, PhD, University of British Columbia, Department of Surgery, Vancouver, BC, Canada
10/12/2021 The Kinetics of Anti-HLA Antibody in Simultaneous Liver-Kidney Transplantation – presented by Matthew Cusick, PhD, University of Michigan Medicine, Department of Pathology, Ann Arbor, MI
10/19/2021 A Modified Flow Cytometric Crossmatch Protocol to Decrease B Cell Background – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
11/2/2021 KIR Testing – presented by Faisal M. Khan, PhD, Hematology Translational Laboratory, Cumming School of Medicine, University of Calgary, AB, Canada
11/9/2021 Missing Self and DSA: Synergy of Two NK Cell Activation Pathways in Kidney Transplantation – presented by Luis Hidalgo, PhD, University of Wisconsin HLA Laboratory, Madison, WI
11/16/2021 Assessment of the Humoral Response to SARS-CoV-2 Infection via Novel Multiplexed Assays – presented by Jonathan Maltzman, MD, PhD, Stanford University, Palo Alto, CA
11/23/2021 Machine Learning to Analyze Immune Cellular Compartments in Pre-Transplant Patients – presented by Franz Fenninger, PhD, University of British Columbia, Vancouver General Hospital, BC, Canada
11/30/2021 Kidney Allocation 2021 – presented by Sam Ho, PhD, Histocompatibility and Infectious Disease Testing Laboratory, Gift of Hope Organ & Tissue Donor Network, Itasca, IL
12/21/2021 Tips for Determining if an Antibody Specificity is Relevant – presented by Matthew Najor, PhD, MedStar Georgetown University Hospital Histocompatibility Laboratory, Washington, DC
2020
5/12/2020 HLA: What’s in a Name and Why It Is So Confusing – presented by Sandra Rosen-Bronson, PhD, MedStar Georgetown University Hospital Histocompatibility Laboratory, Washington, DC
5/19/2020 Evaluating the Role for HLA Mismatched Unrelated Donor Transplantation – presented by Stephen Spellman, MBS, Immunobiology Research, Center for International Blood and Marrow Transplant Research, Minneapolis, MN
6/16/2020 Serum Dilution as a Predictive Biomarker for Peri-Operative Desensitization – presented by Olga Timofeeva, PhD, MedStar Georgetown University Hospital, Washington, DC
6/23/2020 Looking Under the Hood: Illumina MiSeq – presented by Claire Attwooll, PhD, Illumina, Inc., San Diego, CA
6/30/2020 CAR T-Cells: The Good, The Bad, and the Ugly – presented by Alex Dorcy, BSN, RN, BMTCN, Stem Cell Transplant and Cellular Immunotherapy Program, Medstar Georgetown University Hospital, Washington, DC
7/14/2020 Antibody-Mediated Rejection Across Solid Organ Transplants: Manifestations, Mechanisms, and Therapies – presented by Nicole Valenzuela, PhD, UCLA Immunogenetics Center, Department of Pathology and Laboratory Medicine, Los Angeles, CA
7/21/2020 Understanding ABO Blood Groups – presented by Mohamed Alsammak, MD, Temple University Hospital Transfusion Medicine, Philadelphia, PA
7/28/2020 Selecting and Implementing Laboratory Automation – presented by Brian Iglehart, MS, CHS, Johns Hopkins University Immunogenetic Laboratory, Baltimore, MD
8/11/2020 The Paperless HLA Laboratory – presented by Julie Houp, CHS, University of Alabama, Birmingham, AL
8/25/2020 Demystifying Natural Killer Cells – presented by Luis Hidalgo, PhD, University of Wisconsin HLA Laboratory, Madison, WI
9/15/2020 Machine Learning Strategies for Detecting Epistatic and Heterogeneous Associations in Precision Histocompatibility – presented by Ryan Urbanowicz, PhD, Perelman School of Medicine University of Pennsylvania, Philadelphia, PA
9/29/2020 Pre-Transplant Alloimmune Risk Assessment for Precision Medicine – presented by Chris Wiebe, MD, University of Winnipeg, MB, Canada
10/6/2020 Looking Under the Hood: Luminex xMAP Technology – presented by Heather Darby, MSc, Field Applications Scientist, Luminex Corporation, Austin, TX
10/13/2020 Non-HLA Donor-Recipient Mismatches in Kidney Transplant – presented by Madhav Menon, MBBS, MD, Ichan School of Medicine at Mount Sinai, New York, NY
10/27/2020 Beyond Antigens: Strategies for Utilizing HLA Amino Acid Sequence Data in the Organ Allocation System – presented by Loren Gragert, PhD, Tulane University School of Medicine, New Orleans, LA
11/3/2020 Understanding Common, Intermediated and Well-Documented HLA Alleles in World Populations: CIWD 3.0.0 – presented by Carolyn Hurley, PhD, The C.W. Bill Young Marrow Donor Recruitment and Research Program, Department of Oncology, Georgetown University, Washington, DC
11/10/2020 GO Halifaster – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
11/24/2020 Flowcytometry for the Novice – presented by Ricardo Lopez, MS, Department of Pathology, King Fahad Specialist Hospital, Dammam, Saudi Arabia
12/1/2020 Non-Conforming Events and Root Cause Analysis – presented by Mary Libby, BS, CHS, Allogen Laboratories, Cleveland Clinic Foundation, Cleveland, OH
12/15/2020 Chimerism Testing: Principles and Practice for the Novice – presented by Matthew Najor, PhD, MedStar Georgetown University Hospital Histocompatibility Laboratory, Washington, DC
2019
5/14/2019 Potential Clinical Relevance of Anti-HLA-DP Antibodies – presented by Jeffrey Kiernan, PhD, University Health Network, Toronto, ON, Canada
5/21/2019 Virtual Crossmatch Using Molecular HLA Typing Data – presented by Loren Gragert, PhD, Tulane University School of Medicine, New Orleans, LA
6/18/2019 Risk Epitope Mismatches Associated with de novo Donor Specific Antibody – presented by Jennifer McCaughan, MBChB, PhD, Belfast City Hospital, Belfast, UK
6/25/2019 Fundamental Concepts for Understanding Antibody Recognition of Protein Antigens – presented by Neil Greenspan, MD, PhD, University Hospitals Cleveland Medical Center, Cleveland, OH
7/ 9/2019 Targeting Notch Signaling to Prevent Graft-Versus-Host Disease – presented by Ivan Maillard, MD, PhD, University of Pennsylvania, Philadelphia, PA
7/16/2019 HLA Allele and Haplotype Frequencies Characterized Using NGS – presented by Marcelo Fernandez-Vina, PhD, Stanford University School of Medicine, Palo Alto, CA
7/30/2019 Applying HLA Population Genetics to Solid Organ Transplantation: Re-thinking the Calculated Panel Reactive Antibody – presented by Loren Gragert, PhD, Tulane University School of Medicine, New Orleans, LA and Evan Kransdorf , MD, Cedars-Sinai Heart Institute, Cedars–Sinai Medical Center, Los Angeles, CA
8/13/2019 Donor-Derived Cell-Free DNA: A Marker of Transplant Rejection – presented by Sean Agbor-Enoh, MD, Laboratory of Transplantation Genomics, National Heart Lung Blood Institute, NIH, Bethesda, MD
9/10/2019 The African Diaspora and Its Implications for Transplant – presented by Martin Maiers, MS, Bioinformatics Research, National Marrow Donor Program, Minneapolis, MN
10/1/2019 Donor and Cord Blood Selection Guidelines 2019 – presented by Jason Dehn, MPH, Collection and Laboratory Services, National Marrow Donor Program, Minneapolis MN and Joseph A. Pidala, MD, PhD, Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
10/8/2019 IdeS (Imlifidase): New Hope for Highly Sensitized Transplant Patients - presented by Bonnie Lonze, MD, PhD, NYU Langone Transplant Institute, New York, NY
10/15/2019 Understanding Your Laboratory’s Quality Plan – presented by Jenifer Williams, BS, CHS, and Parivash Abbasalizadeh, BS, MT, Baylor University Medical Center, Dallas, TX
10/22/2019 Characterization of HLA Antibody Specificities in the NGS Era – presented by Marcelo Fernandez-Vina, PhD, Stanford University School of Medicine, Palo Alto, CA
10/29/2019 HLA Typing for the Novice: How Did We Get Here? – presented by Donna Phelan, CHS, Barnes-Jewish Hospital, St. Louis, MO, Brian Duffy, MA, CHS, Barnes-Jewish Hospital, St. Louis, MO, and Harriet Noreen, CHS, Fairview University MC, Minneapolis, MN
11/5/2019 Differential Reactivity of Monoclonal Antibodies for the Detection of HLA Class II Surface Expression – presented by Esme Dijke, PhD, University of Alberta, Edmonton, AB, Canada
11/12/2019 Histocompatibility Assay Validation: Unique Challenges – presented by Sam Ho, PhD, Gift of Life Michigan, Ann Arbor, MI
11/19/2019 Quality Challenges in the Next Generation Sequencing Era – presented by Deborah Ferriola, BS, CHT, Children's Hospital of Philadelphia, Philadelphia, PA
12/3/2019 Antibody Epitope Analysis for the Novice – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
12/10/2019 The Progress and Biology of De Novo Alloantibody – presented by Mark Haas, MD, PhD, Cedars-Sinai Medical Center, Los Angeles, CA
12/17/2019 Computational Approaches to Facilitate Epitope-Based HLA Matching in Solid Organ Transplant – presented by Eric Spierings, PhD, University Medical Center Utrecht, Utrecht, The Netherlands
2018
4/24/2018 A2 to B Kidney Transplantation: Questions and Answers and More Questions – presented by Alexander Gilbert, MD, MedStar Georgetown Transplant Institute, Washington, DC
5/1/2018 Next-Generation HLA Antibody Reagents – presented by Paul Warner, PhD, Bloodworks Northwest, Seattle, WA
5/15/2018 What Does the Immune Response to an Allograft Look Like: Start to Finish – presented by Robert Fairchild, PhD, Cleveland Clinic Foundation, Cleveland, OH
5/22/2018 Ethical Implications of Organ Donation Entering the Social Media “Space” – presented by Macey Henderson, JD, PhD, Johns Hopkins School of Medicine, Baltimore, MD
6/12/2018 Next-Generation HLA Antibody Analysis Using HLA Matchmaker – presented by Paul Sikorski, MS, CHS, and Kevin Harrell, CHS, Thermo Fisher Scientific, Canoga Park, CA
6/19/2018 HLA: From Genetics to Epitopes – presented by Frans Claas, PhD, Leiden University Medical Center, Leiden, the Netherlands
6/26/2018 Organ Allocation in 2018: How Did We Get Here – presented by Alison Wilhelm, MPP, and James Alcorn, JD, United Network for Organ Sharing, Richmond, VA
7/10/2018 HaploStats: A Tool That’s Not Just for Donor Search – presented by Tami Maus, MT, CHTC, and Kelly Lazration, MPP, CHT, National Marrow Donor Program, Minneapolis, MN
7/24/2018 Antibody Mediated Rejection in Heart Transplantation – presented by Jon Kobashigawa, MD, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA
7/31/2018 UNOS Histocompatibility Committee Update – presented by Robert Bray, PhD, Emory University, Atlanta, GA and Cathi Murphey Half, PhD, Southwest Immunodiagnostics, Inc., San Antonio, TX
8/7/2018 Dissecting the Contribution of Complex Genetic Variation to Human Traits – presented by Melissa Gymrek, PhD, University of California San Diego, San Diego, CA
8/14/2018 The Diverse World of Bugs Within: How the Microbiome Affects Transplantation – presented by Tessa Andermann, MD, MPH, Stanford University, Stanford, CA
8/28/2018 Time to Transition from Empiric to Precision Medicine – presented by Peter Nickerson, MD, University of Manitoba, Winnipeg, MB, Canada
9/18/2018 Advances in Combating Transplant Tourism and Organ Trafficking – presented by John Gill, MD, MS, St Paul’s Hospital, University of British Columbia, Vancouver, BC, Canada
9/25/2018 Effect of Genetic Ancestry on Hematopoietic Stem Cell Transplant Outcome – presented by Abeer Madbouly, PhD, National Marrow Donor Program, Minneapolis, MN
10/16/2018 The Role of Innate Alloreactivity in Transplant Rejection – presented by Martin Oberbarnscheidt, MD, PhD, University of Pittsburgh, Pittsburgh, PA
10/30/2018 Keeping it simple: HLA Testing for Hematopoietic Stem Cell Transplantation - presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
11/6/2018 HLA Antibody Specificity Interpretation for the Novice – presented by Olga Timofeeva, PhD, Temple University, Philadelphia, PA, and Sandra Rosen-Bronson, PhD, MedStar Georgetown University Hospital, Washington, DC
11/20/2018 Crossmatch Interpretation for the Novice – presented by Dong Li, MD, and Sandra Rosen-Bronson, PhD, MedStar Georgetown University Hospital, Washington, DC
12/4/2018 Flow Cytometric Crossmatch QC Challenges – presented by Matthew Najor, PhD, MedStar Georgetown University Hospital, Washington, DC
2017
4/25/2017 Understanding Outcomes Studies – presented by Ruta Brazauskas, PhD, Division of Biostatistics, Medical College of Wisconsin, Madison, WI
5/9/2017 Taking Good Quality Processes and Making Them Great – presented by Frederick Strathmann, PhD, NMS Labs, Willow Grove, PA
5/16/2017 Polyreactive Antibody – presented by Emmanuel Zorn, PhD, Columbia University Medical Center, New York, NY
5/23/2017 Next Generation Luminex – presented by Lynn Kilheeney, MT, CHS, UPMC Presbyterian Shadyside, Pittsburgh, PA and Paul Sikorski, MS, CHS, Thermo Fisher Scientific, Canoga Park, CA
6/6/2017 Who Needs NGS: Combining Sanger SBT With Phasing Probes Results in Resolution of the Majority of HLA Variation – presented by Carolyn Hurley, PhD, CW Bill Young Marrow Donor Recruitment and Research Program at Georgetown University Medical Center, Washington, DC
6/20/2017 Validation of HLA Typing by NGS – presented by Eric Weimer, PhD, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
6/27/2017 Flow Crossmatch: When is Negative Not Really Negative and Positive Not Really Positive? – presented by Cathi Murphey Half, PhD, Southwest Immunodiagnostics, Inc., San Antonio, TX
7/18/2017 The Application of NGS to HLA Typing: Challenges in Data Interpretation – presented by Marcelo Fernández-Viña, PhD, Stanford University School of Medicine, Stanford, CA
7/1/2017 Autoimmunity in Transplantation and its Clinical Relevance – presented by Marie-Josee Hebert, MD, University of Montreal, Montreal, QC, Canada
8/8/2017 Non-HLA Factors Considered for Donor Selection – presented by Bronwen Shaw, MD, PhD, Center for International Blood and Marrow Transplant Research and the Medical College of Wisconsin, Milwaukee, WI
8/15/2017 Back to the Future: HLA Matching to Improve Outcomes – presented by Peter Nickerson, MD, University of Manitoba, Winnipeg, MB, Canada
8/29/2017 Web Tools for Donor Search – presented by Jason Dehn, MPH, National Marrow Donor Program, Minneapolis, MN
9/26/2017 Application of HLA Epitope-Based Matching in the Clinical Transplant Setting. Part I: Antibody Reactivity with Epitopes – presented by Rene Duquesnoy, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA
10/3/2017 Is NGS for Everyone? – presented by Lee Ann Baxter-Lowe, PhD, Children's Hospital Los Angeles, Los Angeles, CA
10/10/2017 Finding the Best Match: Looking to the Epitopes – presented by Anat Tambur, DMD, PhD, Northwestern University, Chicago, IL
10/17/2017 Application of HLA Epitope-Based Matching in the Clinical Transplant Setting. Part II: Pre-Transplant Serum Analysis for Epitope-Specific Antibodies – presented by Rene Duquesnoy, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA
10/24/2017 The Molecular Microscope – presented by Zahra Kashi, PhD, Kashi Clinical Laboratories, Portland, OR
10/31/2017 HLA Amino Acid Polymorphisms and Kidney Allograft Outcomes – presented by Malek Kamoun, MD, PhD, University of Pennsylvania, Philadelphia, PA
11/7/2017 Post-Transplant Monitoring: It’s More Than Just DSA – presented by Alexander Gilbert, MD, Transplant Nephrologist, Kidney and Pancreas Transplant Program, MedStar Georgetown Transplant Institute, Washington, DC
11/14/2017 What’s Wrong With This Picture? Technical and Instrumental Troubleshooting Tips – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
2016
5/3/2016 Diagnosis of Kidney Allograft Rejection: The Nephrologist Perspective – presented by John Friedewald, MD, Northwestern University Feinberg School of Medicine, Chicago, IL
5/17/2016 Diagnosis of Kidney Allograft Rejection: The Histocompatibility Laboratory’s Role – presented by Annette Jackson, PhD, D(ABHI), Johns Hopkins University School of Medicine, Baltimore, MD
5/24/2016 Diagnosis of Kidney Allograft Rejection: The Pathologist Perspective – presented by Michael Mengel, MD, University of Alberta, Edmonton, AB, Canada
6/7/2016 HLA Ambiguity Resolution by Next-Generation Sequencing – presented by Alex Lindell, BS, MBA, Associate Director, Market Development, Applied Genomics, Illumina Inc., San Diego, CA
6/21/2016 Innovative Tools for HLA Epitope Analysis – presented by, Semiramis J.H. do Monte, MD, Immunogenetics and Molecular Biology Laboratory, Federal University of Piauí, Teresina, Brazil
6/28/2016 Subpopulations of Bone Marrow Plasma Cells – presented by David Allman, PhD, University of Pennsylvania, Philadelphia, PA
7/12/2016 The Microbiome as an Immune Modulator – presented by Sivadasan Kanangat, PhD, Rush University Medical Center, Chicago, IL
7/19/2016 Flow Crossmatch: In Pursuit of Perfection – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
7/26/2016 HLA Diversity in the Era of NGS – presented by Marcelo Fernández-Viña, PhD, Stanford University, Stanford, CA
8/2/2016 Basics of the HLA System – presented by Rajalingam Raja, PhD, University of California, San Francisco, CA
8/23/2016 The Basics of KIR-HLA Complexity – presented by Rajalingam Raja, PhD, University of California, San Francisco, CA
9/20/2016 The Challenges of HLA-DP in Deceased Donor Organ Allocation – presented by Robert Bray, PhD, Howard Gebel, PhD, and Geoffrey Smith, MD, Emory University, Atlanta, GA
10/11/2016 Hematopoietic Stem Cell Donor Selection 2016 – presented by Jennifer Wilder, RN, BSN, OCN, CHTC, NIH Unrelated Donor Hematopoietic Stem Cell Transplant Program, Bethesda, MD
10/25/2016 Complement Fixing Antibody Testing in Kidney Transplantation – presented by Gansuvd Balgansuren, MD, PhD, Seattle Cancer Care Alliance, Clinical Immunogenetics Laboratory, Seattle, WA
11/1/2016 Kidney Allocation 2016 – presented by Sam Ho, PhD, Gift of Life Michigan, Ann Arbor, MI
11/8/2016 NK Cell Responses to HLA Antibodies – presented by Luis Hidalgo, PhD, University of Alberta Hospitals, Edmonton, AB, Canada
11/15/2016 Matched Unrelated versus Haploidentical Hematopoietic Stem Cell Transplant – presented by Stephen Spellman, MBS, Immnobiology & Observational Research, CIBMTR, Minneapolis, MN
11/29/2016 Virtual Crossmatching in 2016 – presented by Dong Li, MD, Sandra Rosen-Bronson, PhD, MedStar Georgetown University Hospital, Washington, DC and Olga Timofeeva, PhD, Temple University, Philadelphia, PA
12/6/2016 NGS for Beginners – presented by Medhat Askar, MD, PhD, Baylor University Medical Center, Dallas, TX
12/13/2016 Solid Phase Antibody Assay Optimization – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
2015
4/14/2015 Faster-Cooler: Optimizing Your Antibody Detection Assays – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
5/12/2015 Infectious Disease and the Transplant Patient – presented by Robin K. Avery, MD, Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD
5/19/2015 HLA Sensitization: Desensitization or Donor Exchange – presented by Dorry Segev, MD, PhD, Department of Surgery, Johns Hopkins University, Baltimore, MD
6/2/2015 Transplant Immunology – presented by Alexander Gilbert, MD, Transplant Nephrologist, Kidney and Pancreas Transplant Program, Medstar Georgetown Transplant Institute, Washington, DC
6/9/2015 Innate Immunity – presented by Amy Hahn, PhD, Albany Medical College, Transplant Immunology Laboratory, Albany, NY
6/16/2015 Matching Strategies in Solid Organ Transplant – presented by H. Michael Cecka, PhD, UCLA Immunogenetics Center, Los Angeles, CA
6/30/2015 HLA Typing by Next-Generation Sequencing: Laboratory Logistics – presented by Curt Lind, CHS, One Lambda, Thermo Fisher Scientific, Canoga Park, CA
7/21/2015 Nationwide Paired Kidney Exchange: Laboratory Logistics – presented by Myra Coppage, PhD, University of Rochester Medical Center, Rochester, NY
8/4/2015 Understanding Transplant Rejection – presented by Alexander Gilbert, MD, Transplant Nephrologist, Kidney and Pancreas Transplant Program, Medstar Georgetown Transplant Institute, Washington, DC
8/18/2015 Using KIR to Guide Donor Selection – presented by E. Victoria Turner, PhD, St. Jude Children’s Hospital, Memphis, TN
8/25/2015 Dealing with DSA: It Takes a Team – presented by Milagros Samaniego-Picota, MD, Medical Director, Kidney and Pancreas Transplantation, University of Michigan, Ann Arbor, MI
9/1/2015 The Scientific Registry of Transplant Recipients (SRTR) -presented by Ajay K. Israni, MD, MS, Deputy Project Director, Scientific Registry of Transplant Recipients, Minneapolis, MN
10/13/2015 Clinical Impact of Antibodies and Therapeutic Strategies for AMR Across the Age Spectrum-Infants, Children, Adolescents – presented by Simon Urschel, MD, Assistant Professor of Pediatrics and Immunology, Clinical Director Pediatric Cardiac Transplantation, University of Alberta, Stollery Children's Hospital, Edmonton, AB, Canada
10/20/2015 Kidney Allocation 2015: The Impact on HLA Laboratories – presented by Julie A. Houp, CHS, Immunogenetics Laboratory, Johns Hopkins School of Medicine, Baltimore, MD
11/3/2015 De novo DSA: Risk Factors and Determinants of Prognosis – presented by Chris Wiebe, MD, Departments of Medicine and Immunology, University of Manitoba, Winnipeg, MB, Canada
11/10/2015 Immunogenetics 2.0: Considerations for HCT Beyond HLA Matching – presented by Medhat Askar, MD, PhD, Allogen Laboratories, Cleveland Clinic, Cleveland, OH
11/17/2015 Mapping the Match: Genetic Ancestry and Self-Identification in the 21st Century America – presented by Jill A. Hollenbach, PhD, MPH, University of California, San Francisco School of Medicine, San Francisco, CA
12/8/2015 UNOS Histocompatibility Committee Update – presented by Dolly B. Tyan, PhD, Histocompatibility, Immunogenetics & Disease Profiling Laboratory, Stanford University, Palo Alto, CA
12/15/2015 Challenging Antibody Cases: Teachable Moments – presented by Dong Li, MD, and Olga Timofeeva, PhD, MedStar Georgetown University Hospital, Washington, DC
12/22/2015 Angiotensin II Type-1 Receptor Antibodies and Rejection Risk in Living Donor Kidney Transplants – presented by Kelley M.K. Haarberg, MS, PhD, Northwestern University, Chicago, IL
2014
4/3/2014 Umbilical Cord Blood: Banking and Transplantation – presented by Joanne Kurtzberg, MD, Director of Pediatric Blood and Marrow Transplantation, Duke University School of Medicine, Durham, NC
4/29/2014 Inflammatory Tipping Points in the Complement Cascade – presented by William Baldwin, MD, PhD, Cleveland Clinic Lerner Research Institute, Cleveland, OH
5/6/2014 Current Data on the Clinical Relevance of C1q Binding Assays in Solid Organ Transplantation – presented by John Lunz, PhD, University of Pittsburgh, Pittsburgh, PA
5/20/2014 Real-Time PCR for HLA Typing – presented by Peter Lalli, PhD, Histocompatibility Laboratory, Carolinas Health System, Charlotte, NC
6/3/2014 Disconnects with Solid-Phase HLA Antibody Assays: Reconnecting the Dots – presented by Tiffany Roberts-Wilson, PhD, and Gizem Tumer, MD, Emory University Hospital, Atlanta, GA
6/17/2014 Chimeric Antigen Receptor T Cells: Promising Treatments for Hematologic Malignancies – presented by Marcela Maus, MD, PhD, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
6/24/2014 Innate Immune Effector Mechanisms in Antibody-Mediated Rejection – presented by Luis Hidalgo, PhD, Walter Mackenzie Health Sciences Centre, University of Alberta, Edmonton, AB, Canada
7/15/2014 B Cell Basics – presented by Maria-Luisa Alegre, MD, PhD, Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL
7/22/2014 Permissible Mismatches and Mismatching Effects in Hematopoietic Stem Cell Transplant – presented by Marcelo Fernandez-Vina, PhD, Stanford Medical School Blood Center, Palo Alto, CA
9/9/2014 Fine-Mapping of HLA Associations for Hematologic Diseases using Registry Data – presented by Loren Gragert, MS, Bioinformatics Research, National Marrow Donor Program, Minneapolis, MN
9/16/2014 Flow Cytometry Boot Camp: Building Your Knowledge and Improving Your Abs Detection – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
9/23/2014 Transfusion Medicine: Unique Challenges for Transplant Patients – presented by Julie Cruz, MD, Indiana BC, Indianapolis, IN
9/30/2014 Risk Factors for and Impact of De Novo DSA – presented by Chris Wiebe, MD, Departments of Medicine and Immunology, University of Manitoba, Winnipeg, MB, Canada
10/7/2014 The Registry Diversity Project: Global HLA Haplotype Analysis – presented by Abeer Madbouly, PhD, National Marrow Donor Program, Minneapolis, MN
10/14/2014 Vaccinations and Allosensitization – presented by Thomas Ellis, PhD, HLA Laboratory, University of Wisconsin School of Medicine, Madison, WI
10/28/2014 Treating Donor Specific Antibody: Is There a Role for Proteasome Inhibitor Therapy? – presented by E. Steve Woodle, MD, Department of Surgery, Division of Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH
11/4/2014 Custom-Tailoring Your C1q Assay to Fit Your Transplant Program’s Needs – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada and Olga Timofeeva, PhD, MedStar Georgetown University Hospital, Washington, DC
11/18/2014 NGS Data Standards: Après Moi, le Déluge – presented by Martin Maiers, MS, National Marrow Donor Program, Minneapolis, MN
12/2/2014 US Kidney Allocation 2014 – presented by Lee Ann Baxter-Lowe, PhD, University of California San Francisco, San Francisco, CA
12/9/2014 HLA Antibody Detection: Then and Now – presented by Dong Li, MD, and Olga Timofeeva, PhD, MedStar Georgetown University Hospital, Washington, DC
2013
3/26/2013 Interpreting Flowcytometric Crossmatches – presented by Nancy Higgins, MT, CHS, Indiana University Health Methodist, Indianapolis, IN
4/16/2013 HSC Donor Selection Guidelines – presented by Stephen Spellman, MBS, National Marrow Donor Program, Minneapolis, MN
4/23/2013 Genomics: Transforming Medicine – presented by Kenneth Beckman, PhD, Biomedical Genomics Center, University of Minnesota, Minneapolis, MN
5/14/2013 HLA-Haploidentical HSC Transplant – presented by Ephraim Fuchs, MD, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
6/4/2013 DPB1 T-Cell Epitope Matching in HSC Transplant – presented by Bronwen Shaw, MD, Anthony Nolan Research Institute, Royal Free Hospital, London, UK
6/11/2013 The Role of BLyS and BLyS Receptor in B-Cell Selection and Regulation – presented by Michael Cancro, PhD, University of Pennsylvania, Philadelphia, PA
6/18/2013 Antibody Specificity Detection and Definition of Epitopes – presented by Marcelo Fernandez-Vina, PhD, Stanford Medical School Blood Center, Palo Alto, CA
6/25/2013 Predictive Biomarkers in GVHD – presented by John Levine, MD, University of Michigan, C.S. Mott Children’s Hospital, Ann Arbor, MI
7/16/2013 Regulatory B-Cells – presented by R. Carlin Walsh, PharmD, BCPS, Northwestern University, Chicago, IL
7/23/2013 CPT Code Update – presented by Sandra Helman, PhD, Georgia Health Sciences University, Augusta, GA
7/30/2013 Antibody Mediated Rejection in Liver Transplantation – presented by Jacqueline O’Leary, MD, MPH, Baylor University Medical Center, Dallas, TX
9/10/2013 UNOS Histocompatibility Committee Update – presented by Lee Ann Baxter-Lowe, PhD, University of California San Francisco, San Francisco, CA
9/17/2013 Genetic Ancestry: A Guide for Donor Search – presented by Abeer Madbouly, PhD, National Marrow Donor Program, Minneapolis, MN
9/24/2013 Analysis of HLA Sequence Feature Associations – presented by Richard Scheuermann, PhD, J. Craig Venter Institute, San Diego, CA
10/1/2013 The Role of Complement in Solid Organ Transplantation – presented by Jennifer Zitzner, PhD, Northwestern University, Chicago, IL
10/15/2013 HLA Class II Antibody Epitopes – presented by Anat Tambur, DMD, PhD, Northwestern University, Chicago, IL
10/22/2013 Next-Generation Sequencing – presented by Kenneth Beckman, PhD, Biomedical Genomics Center, University of Minnesota, Minneapolis, MN
11/5/2013 Structural Perspectives of the HLA Antibody Response in Transplantation – presented by Rene Duquesnoy, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA
11/12/2013 A Web-Based Registry of Antibody-Defined HLA Epitopes – presented by Marilyn Marrari, BA, CHS, University of Pittsburgh Medical Center, Pittsburgh, PA
12/3/2013 The Alloimmune Response – presented by Lee Ann Baxter-Lowe, PhD, University of California San Francisco, San Francisco, CA
2012
3/20/2012 NMDP Matching Guidelines: What’s New – presented by Carolyn Hurley, PhD, Georgetown University and the C. W. Bill Young Marrow Donor Program, Washington, DC
4/17/2012 Introduction to Bone Marrow Transplant – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
5/1/2012 Understanding the ASHI Accreditation Process – presented by Melissa Weeks, BS, Accreditation Manager, ASHI Accreditation Office, St. Paul, MN
5/15/2012 Organ Donation through the Eyes of the OPO Coordinator – presented by Immanuel Rasool, BS, Washington Regional Transplant Community, Annandale, VA
6/26/2012 The C1q Assay: A Useful Tool in Guiding Clinical Practice – presented by John Lunz, PhD, University of Pittsburgh School of Medicine, Pittsburgh, PA
7/31/2012 The Center for International Blood and Marrow Transplant Research (CIBMTR) – presented by Stephen Spellman, MBS, National Marrow Donor Program, Minneapolis, MN
8/14/2012 Bortezomib (Velcade) for Depletion of Plasma Cells and Removal of HLA Antibodies – presented by Matthew Everly, PharmD, Terasaki Foundation Laboratory, Los Angeles, CA
8/28/2012 Harmonization of HLA Data Reporting – presented by Dawn Wagenknecht, MS, CHS, St. Francis Hospital, Indianapolis, IN
9/11/2012 Single Cell Mass Cytometry – presented by Sean Bendall, PhD, Department of Microbiology and Immunology, Stanford University, Stanford, CA
9/18/2012 The Immunogenomics Data-Analysis Working Group – presented by Jill Hollenbach, PhD, Center for Genetics, Children’s Hospital Oakland Research Institute, Oakland, CA
9/25/2012 Six-Locus High-Resolution HLA Haplotype Frequencies – presented by Loren Gragert, MS, National Marrow Donor Program, Minneapolis, MN
10/16/2012 Biological Function and Clinical Relevance of Antibodies to HLA Antigens – presented by Elaine Reed, PhD, UCLA Immunogenetics Center, Los Angeles, CA
10/30/2012 Clinical Relevance of Donor Specific Antibody (DSA) – presented by Alin Girnita, MD, Transplant Immunology, Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH
11/6/2012 UNOS Histocompatibility Committee Update – presented by Nancy Reinsmoen, PhD, Cedars-Sinai MC, Los Angeles, CA
11/13/2012 The Flowcytometric Crossmatch: A New Approach – presented by Robert Liwski, MD, PhD, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
11/20/2012 The Role of Natural Killer (NK) Cells in Solid Organ Transplantation - presented by Ilias Doxiadis, PhD, Eurotransplant Reference Laboratory, Leiden University Medical Center, The Netherlands
11/27/2012 Antibody Testing Pre- and Post-Transplant: A Clinician’s Perspective – presented by Patricia Campbell, MBChB, MRCP (UK),F, University of Alberta Hospitals, Edmonton, AB, Canada
12/4/2012 HLA-DPA/DPB Haplotypes and Amino Acid Epitopes – presented by Jill Hollenbach, PhD, Center for Genetics, Children’s Hospital Oakland Research Institute, Oakland, CA
12/11/2012 Introduction to T and B Cell Biology – presented by Jennifer Zitzner, PhD, Transplant Immunology Laboratory, Northwestern University, Chicago, IL
12/18/2012 Understanding the Causes of Kidney Transplant Failure – presented by Philip Halloran, MD, PhD, Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
2011
3/29/2011 Medical Terminology for the Histocompatibility Technologist – presented by Eileen Ronsheim, RN, BSN, CMSRN, Kidney Transplant Nurse Practitioner, Georgetown University Hospital, Washington, DC
4/12/2011 Graft Versus Host Disease: Progress Toward Modulation – presented by Christian Capitini, MD, National Cancer Institute, Pediatric Oncology Branch, Bethesda, MD
4/19/2011 The Complement System – presented by Michael Cole, PhD, Department of Microbiology and Immunology, Georgetown University, Washington, DC
4/26/2011 The C1q Assay: Detection of Clinically Relevant Antibodies – presented by Dolly Tyan, PhD, Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford University, Palo Alto, CA
5/24/2011 ASHI Inspection Without Tears – presented by Maurine Davidson, CHS, Immunology Laboratory, University of Minnesota Medical Center, Minneapolis, MN
6/21/2011 Characterization and Clinical Significance of Rare and Null Alleles – presented by Marcelo Fernández-Viña, PhD, University of Texas, M.D. Anderson Cancer Center, Houston, TX
7/19/2011 Tools for Identifying the Best Hematopoietic Stem Cell Donor – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
8/2/2011 HLA Geocoding and Ancestry – presented by Martin Maiers, MS, National Marrow Donor Program, Minneapolis, MN
8/16/2011 Histocompatibility Testing for the New Technologist – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
8/30/2011 Paired Kidney Exchange: The Laboratory’s Perspective – presented by Cathi Murphey, PhD, Southwest Immunodiagnostics, Inc. San Antonio, TX
9/13/2011 HLA Nomenclature 2010 – presented by Steven Marsh, PhD, Anthony Nolan Research Institute, London, UK
9/27/2011 Blood Banking for the Histocompatibility Technologist – presented by Charlene Hubbell, BS, MT (ASC) SBB, SUNY Upstate Medical University, Syracuse, NY
10/11/2011 UNOS Histocompatibility Committee Update – presented by Nancy Reinsmoen, PhD, Cedars-Sinai MC, Los Angeles, CA
11/8/2011 Class, Isotype, and Epitope Patterns of HLA-Specific Alloantibody in Early Versus Late Antibody Mediated Rejection – presented by Alin Girnita, MD, Transplant Immunology, Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH
11/15/2011 Understanding Biomedical Statistics – presented by Brent Logan, PhD, Division of Biostatistics, Institute of Health and Society, Medical College of Wisconsin, Milwaukee, WI
11/22/2011 Antibody Epitope Mapping – presented by Ilias Doxiadis, PhD, Eurotransplant Reference Laboratory, Leiden University Medical Center, Leiden, The Netherlands
11/29/2011 Introduction to Pharmacogenetics – presented by Maria Bettinotti, PhD and Vicky M. Pratt, PhD, Quest Diagnostics Nichols Institute, Chantilly, VA
12/6/2011 Standardizing Solid Phase and Flowcytometric Assays – presented by Robert Bray, PhD and Howard Gebel, PhD, Emory University, Atlanta, GA
12/13/2011 Clinical Significance of DP and DQA Antibody – presented by Anat Tambur, PhD, Northwestern University, Chicago, IL
12/20/2011 Setting up and Optimizing DNA Sequencing for HLA Typing – presented by Nicholas DiPaola, PhD, Ohio State University Medical Center, Columbus, OH
2010
4/6/2010 The Future of Genomics in Transplantation – presented by Philip Halloran, MD, PhD, Alberta Transplant Applied Genomics Center, University of Alberta Edmonton, AB, Canada
4/13/2010 The Biology of a Plasma Cell – presented by Marilia Cascalho, MD, PhD, University of Michigan Department of Surgery, Ann Arbor, MI
4/27/2010 An Overview of Cytokines – presented by Carolyn Hurley, PhD, Georgetown University and the C.W. Bill Young Marrow Donor Program, Washington, DC
5/4/2010 HIV-1 Evolution in Response to Immune Selection Pressure by CTL: Implications for Vaccine Design – presented by Zabrina Brumme, PhD, Simon Fraser University Burnaby, BC, Canada
5/11/2010 Transplant Rejection: It is More Than the Immune System – presented by Linda Ohler, MSN, RN, Georgetown University Hospital Transplant Institute, Washington, DC
5/18/2010 Concepts in the Prevention and Treatment of Acute Cellular Rejection – presented by Christopher Ensor, PharmD, BCPS, Cardiothoracic Transplantation and Mechanical Circulatory Support Johns Hopkins Hospital, Baltimore, MD
6/8/2010 Cord Blood Transplantation – presented by Mary Laughlin, MD, Case Western Reserve University, Allogeneic Bone Marrow Transplant Program Cleveland, OH
6/15/2010 Criteria for Hematopoietic Stem Cell Donor Selection: Choosing the Best From Among Multiple Mismatched Donors – presented by Marcelo Fernández-Viña, PhD, University of Texas, M.D. Anderson Cancer Center Houston, TX
6/22/2010 Paired Kidney Exchanges: Variations on a Theme – presented by J. Keith Melancon, MD, Georgetown University Hospital Transplant Institute, Washington, DC
7/20/2010 Novel Approaches to Managing DSA – presented by Hal Gibson, BS, CHT, One Lambda, Inc. Canoga Park, CA
7/27/2010 Islet Cell Transplant – presented by J. Keith Melancon, MD, Georgetown University Hospital Transplant Institute, Washington, DC
8/10/2010 Update on UNOS/OPTN Policies and Initiatives – presented by Michael Cecka, PhD, University of California Los Angeles, Immunogenetics Center Los Angeles, CA
8/31/2010 Troubleshooting Interference in Solid Phase Antibody Assays – presented by Annette Jackson, PhD, Johns Hopkins University Immunogenetics Laboratory, Baltimore, MD
9/14/2010 Emerging Infectious Diseases and the Transplant Patient – presented by Robin Avery, MD, Cleveland Clinic, Department of Infectious Disease and the Transplantation Center, Cleveland, OH
9/21/2010 The Clinical Significance of Antibody Isotype and Subtype in Transplantation – presented by Alin Girnita, MD, Transplant Immunology, Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH
10/5/2010 Pharmacotherapy for the Prevention and Treatment of Antibody-Mediated Rejection in the Highly Sensitized Candidate – presented by Christopher Ensor, PharmD, BCPS, Cardiothoracic Transplantation and Mechanical Circulatory Support Johns Hopkins Hospital, Baltimore, MD
10/19/2010 Transfusion Related Acute Lung Injury (TRALI) – presented by Karen Nelson, PhD, Puget Sound Blood Center, Immunogenetics Laboratory Seattle, WA
11/23/2010 Understanding Haplotype Frequency Tables and How to Use Them to Facilitate a Donor Search – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital Histocompatibility Laboratory, Washington, DC
11/30/2010 The Sensitized Patient: Stopping Antibody at Its Source – presented by Mark Stegall, MD, Mayo Clinic Rochester, MN
12/7/2010 Significance of de novo Donor-Specific Antibody Post-Kidney Transplant – presented by Peter Nickerson, MD, Canadian Blood Services, Immunogenetics Laboratory Winnipeg, MB, Canada
2009
4/7/2009 Organ Allocation: Equity Vs. Utility – presented by Patricia Campbell, MD, University of Alberta Hospitals, Edmonton, AB, Canada, Carol Pancoska, PhD, Verona, NJ and Michael Cecka, PhD, University of California Los Angeles, Los Angeles, CA
4/28/2009 B cell Responses following Allogeneic Hematopoietic Stem Cell Transplant – presented by David Miklos, MD, PhD, Stanford University, Palo Alto, CA
5/12/2009 Core Concepts in the Prevention, Assessment and Management of GVHD – presented by Stella Davies, MD, PhD, Cincinnati Children’s Medical Center, Cincinnati, OH
5/5/2009 High Sensitivity Chimerism Detection by Real-Time Quantitative PCR – presented by Katherine Lazaruk, PhD, Celera, Alameda, CA
6/16/2009 The XM-One®Crossmatch – presented by Annette Jackson, PhD, Johns Hopkins University Immunogenetics Laboratory, Baltimore, MD
6/30/2009 Population Genetics for Dummies: How to get the Most out of Allele and Haplotype Frequency Tables – presented by Marcelo Fernandez-Vina, PhD, University of Texas, M.D. Anderson Cancer Center, Houston, TX
8/4/2009 Cells and Innate Immunity – presented by Robert Fairchild, PhD, Cleveland Clinic Foundation, Cleveland, OH
8/11/2009 Comparing and Correlating Quantitative Values for Solid Phase Assays – presented by Hal Gibson, BS, CHT, One Lambda, Inc., Canoga Park, CA and Paul Brailey, BS, Hoxworth Blood Center, Cincinnati, OH
8/18/2009 DSA™ : Solid Phase Donor-Specific Antibody Detection and its Utility in a Paired Donor Exchange Program – presented by Annette Blair, MT, CHS, Medical College of Ohio, Toledo, OH and Patrick Adams MS, CHS, Tepnel Lifecodes, Stamford, CT
6/23/2009 Pair Kidney Donation – presented by Michael Rees, MD, PhD, University of Toledo Medical Center, Toledo, OH
8/25/2009 Effects of Anti-Donor Antibodies on Organ Transplant Outcome – presented by Milagros Samaniego, MD, University of Michigan, Ann Arbor, MI
9/1/2009 Standardization of Antibody Identification: The Canadian Experience – presented by Patricia Campbell, MD, University of Alberta Hospitals, Edmonton, AB, Kathryn Tinckam, MD, University Health Network, Toronto Medical Laboratories, HLA Laboratory, Toronto, ON and Peter Nickerson, MD, Canadian Blood Services, Immunogenetics Laboratory, Winnipeg, MB, Canada
9/15/2009 The Role of MICA Organ Transplant Outcome – presented by Medhat Askar, MD, PhD, Cleveland Clinic Foundation, Cleveland, OH
9/22/2009 The Aging Stem Cell and its Niche: Implications for Stem Cell Function – presented by James DeGregori, PhD, University of Colorado, Denver, CO
9/29/2009 Mechanisms of Altered Lymphocyte Function in Type I Diabetes – presented by Jane Buckner, MD, Benaroya Research Institute, Seattle, WA
10/6/2009 HLA Typing Beyond Basics: Impact of Sample Source, Sample Integrity and Typing Method Limitations – presented by Neng Yu, MD, American Red Cross New England Region, Dedham, MA
10/13/2009 Antibody Conundrums – presented by Robert Bray, PhD and Howard Gebel, PhD, Emory University, Atlanta, GA
10/27/2009 Biomarkers in Transplantation – presented by Allan Kirk, MD, Emory University, Atlanta, GA
12/1/2009 Genomic Profile of Operational Tolerance – presented by Minnie Sarwal, MD, PhD, Stanford University, Palo Alto, CA
12/8/2009 Transplant Tourism – presented by Francis Delmonico, MD, Harvard Medical School, Boston, MA
2008
4/1/2008 The Sensitized Patient: Is One Therapy More Effective Than Another? – presented by James Gloor, MD, Mayo Clinic and Foundation, Rochester, MN
4/15/2008 Strategies for Ambiguity Resolution – presented by Brian Iglehart, MS, CHS, Johns Hopkins University, Baltimore, MD
4/22/2008 Do We Still Need a Prospective Crossmatch? – presented by Karen Nelson, PhD, Puget Sound Blood Center, Seattle, WA and Peter Nickerson, MD, Canadian Blood Services, Immunogenetics Laboratory, Winnipeg, MB, Canada
5/6/2008 HLA Typing Challenges in Hematopoietic Stem Cell Transplant – presented by Marcelo Fernandez-Vina, PhD, University of Texas, M.D. Anderson Cancer Center, Houston, TX
5/13/2008 HLA From Start to Finish: How Genetic Information Specifies an Immune Response – presented by Carolyn Hurley, PhD, Georgetown University Medical Center, Washington, DC
5/20/2008 HLA Typing Beyond Transplantation: Pharmacogenomics and Diagnostics – presented by Maria Bettinotti, PhD, Quest Diagnostics Nichols Institute, HLA and Immunogenetics, Chantilly, VA
6/24/2008 QIAxcel: An Automated Approach for SSP Electrophoresis – presented by David Senitzer, PhD, City of Hope National Cancer Center, Duarte, CA
7/22/2008 Quality Assay Results? It’s All About Technique – presented by Hal Gibson, BS, CHT, One Lambda, Inc., Canoga Park, CA
7/29/2008 What is a Quality Assurance Program? – presented by Charlene Hubbell, BS, MT, SBB, SUNY Upstate Medical University, HLA Laboratory, Syracuse, NY
8/12/2008 Non-HLA Genomics and AlloTransplant Outcome – presented by Charles Mullighan, MD, St Jude Children’s Research Hospital, Department of Pathology, Memphis, TN
8/19/2008 The DynaChip™ Antibody Assay: A User’s Perspective – presented by Renato Vega, BS, CHS, Johns Hopkins University, Baltimore, MD
8/26 /2008 STR Analysis for Monitoring Hematopoietic Stem Cell Transplant Recipients – presented by David Senitzer, PhD, City of Hope National Cancer Center, Histocompatibility Laboratory, Duarte, CA
9/9/2008 Transplant Tolerance: Are We There Yet? – presented byMegan Sykes, MD, Massachusetts General Hospital, Transplantation Biology Research Center, Boston, MA
9/23/2008 The Role of Minor Histocompatibility Antigens in Hematopoietic Stem Cell Transplant – presented by Thomas Ellis, PhD, Blood Center of Wisconsin, Milwaukee, WI
9/30/2008 Predicting Crossmatch Outcome: Approaching Virtual Reality – presented by Paul Warner, PhD and Ruby Siegel, MS, CHS, Puget Sound Blood Center, Seattle, WA
10/14/2008 The Panel Reactive T Cell (PRT) Assay – presented by Peter Heeger, MD, Mount Sinai School of Medicine, Transplant Institute and Institute of Immunology, New York, NY
11/18/2008 Update 2008: The Future of Kidney Allocation in the U.S. – presented by M. Sue Leffell, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
11/25/2008 Immunogenomics of Hematopoietic Cell Transplantation – presented by Effie Petersdorf, MD, Fred Hutchinson Cancer Research Center, Seattle, WA
12/2/2008 Immunosuppression Options: How Histocompatibility Test Results Help Guide Clinical Descisions – presented by Kathryn Tinckam, MD, University Health Network, Toronto Medical Laboratories, Toronto, ON, Canada
12/9/2008 The Joint Transplant Histocompatibility Conference: A Progress Report – moderated by Ronald Kerman, PhD, University of Texas Medical School, Houston, TX
2007
3/27/2007 Is Hematopoietic Stem Cell Donation Right for Me? – presented by Judith Lawrence, RN, Donor Stem Cell Coordinator, Georgetown University Hospital, Washington, DC and David Means, MPH, Workup Supervisor, C.W. Bill Young Marrow Donor Program, Rockville, MD
4/3/2007 Getting to Know the T Cell and Its Receptor – presented by Carolyn Hurley, PhD, Georgetown University and the C.W. Bill Young Marrow Donor Program, Washington, DC
4/17/2007 Hematopoietic Stem Cell Transplantation from the Patient’s Perspective – presented by Jennifer Wilder, RN, BSN, ONC, Hematopoietic Stem Cell Transplant Program, National Institutes of Health, Bethesda, MD
5/1/2007 Solid Phase Antibody Assays: Their Power and Their Pitfalls – presented by Karen Nelson, PhD, Puget Sound Blood Center, Seattle, WA
5/15/2007 Therapeutic Protocols: Challenges and Resolutions – presented by Benita Book, MS, Transplant Immunology Laboratory, Indiana University Department of Surgery, Indianapolis, IN and Nancy Higgins, MT, CHS, Transplant Immunology Laboratory, Methodist Hospital, Indianapolis, IN
5/22/2007 Immunogenetics for Beginners – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
6/5/2007 Pillow Talk: Peptide and MHC Interactions – presented by David Eckels, PhD, University of Utah School of Medicine, Salt Lake City, UT
6/19/2007 Unique and Challenging Cases in the HLA Typing Laboratory – presented by Neng Yu, MD, American Red Cross New-England Region, Dedham, MA
6/ 26/2007 Organ Donation Through the Eyes of the OPO – presented by Andrea Tighe, RN, CPTC, Procurement Manager, LifeSource, St Paul, MN
7/17/2007 T Cell Directed Therapies – presented by John O’Shea, MD, Scientific Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD
7/24/2007 Small Bowel Transplantation – presented by Stuart Kaufman, MD, Medical Director, Intestinal Transplantation, Georgetown University Hospital and Children’s National Medical Center, Washington, DC
7/31/2007 Cord Blood Transplantation – presented by Mary Halet, BS, CHTC, Manager of Cord Blood Program, National Marrow Donor Program, Minneapolis, MN
8/7/2007 Neuroimmunology – presented by Jonathan Godbout, PhD, Molecular Virology, Immunology and Medical Genetics, Ohio State University, Columbus, OH
8/21/2007 DNA Sequencing for Beginners – presented by Denise Heaney, PhD, Emory University Hospital, Atlanta, GA
8/28/2007 The Effects of HLA and KIR Genes on Disease Susceptibility and Outcome – presented by Mary Carrington, PhD, Human Genetics Laboratory, National Cancer Institute at Frederick, Frederick, MD
9/18/2007 Update 2007: The Future of Kidney Allocation in the U.S. – presented by M. Sue Leffell, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
9/25/2007 The Ethics of Stem Cell Research – presented by Kevin FitzGerald, SJ, PhD, The David Lauler Chair in Catholic Health Care Ethics, Center for Clinical Bioethics and Department of Oncology, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC
10/23/2007 The Role of KIR and KIR Ligands in HCS Transplant Outcome and Disease Relapse – presented by Katharine Hsu, MD, Bone Marrow Transplantation, Memorial Sloan Kettering Cancer Center, New York, NY
11/13/2007 Transplanting the Highly Sensitized Patient – presented by Kathryn Tinckam, MD, MMSc, FRCPC, Renal Division and Tissue Typing Laboratory, Brigham and Women’s Hospital, Boston, MA
11/20/2007 HLA Matching for Hematopoietic Stem Cell Transplantation – presented by Stephanie Lee, MD, MPH, Fred Hutchinson Cancer Research Center, Seattle, WA
2006
3/7/2006 An Overview of Immunology – presented by Carolyn Hurley, PhD, Georgetown University and the C.W. Bill Young Marrow Donor Program, Washington, DC
4/18/2006 Regulator T-Cells – presented by William Burlingham, PhD, University of Wisconsin, Madison, WI
5/2/2006 Effector Mechanisms of Antibody and Complement – presented by William Baldwin, MD, PhD, Johns Hopkins University School of Medicine, Baltimore, MD
5/16/2006 Significance of Cytokine Polymorphism in Hematopoietic Transplantation – presented by Riddhish Shah, MBBS, PhD, Georgetown University, Washington, DC
5/23/2006 Thermal Cycler Quality Control and PCR Validation – presented by Mary Span, MSc, Cyclertest, B.V., Landgraaf, The Netherlands
6/6/2006 The Organ Transplant Breakthrough Collaborative – presented by Virginia McBride, RN, MPH, CPTC, Department of Health and Human Services, Health Resources and Services Administration, Bethesda, MD
6/20/2006 Lipid Rafts and B-Cell Activation – presented by Susan Pierce, PhD, National Institute of Allergy and Infectious Disease, Bethesda, MD
6/27/2006 An Introduction to HapLogic™ – presented by Judy Davis, CHTC, National Marrow Donor Program, Minneapolis, MN
7/11/2006 The Role of Innate Immunity in Reproduction – presented by Danny Schust, MD, Boston University School of Medicine, Boston, MA
7/18/2006 Real Time PCR – presented by Mary Span, MSc, Cyclertest, B.V., Landgraaf, The Netherlands
8/1/2006 DNA Extraction from A to Z – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
8/15/2006 Standardization of Flowcytometric Assays – presented by Wayne Shumway, CHS, LifeLink Foundation, Inc., Tampa, FL
8/22/2006 Population Genetics 101 – presented by Richard Single, PhD, University of Vermont, Burlington, VT
8/29/2006 Calculating the Probability of a Positive Crossmatch – presented by Robert Bray, PhD, and Howard Gebel, PhD, Emory University Hospital, Atlanta, GA
9/19/2006 Graft Versus Host Disease: Its Types and Manifestations – presented by Richard Maziarz, MD, Oregon Health and Science University, Portland, OR
9/26/2006 Sequence-Based Typing – presented by William Hildebrand, PhD, and Steven Cate, University of Oklahoma Health Sciences Center, Oklahoma City, OK
10/3/2006 Histocompatibility Testing for Beginners – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
11/7/2006 An Introduction to Proteomics – presented by James Baraniuk, MD, Georgetown University Hospital, Washington, DC
11/21/2006 The Future of Kidney Allocation in the U.S. – presented by Mark Stegall, MD, Mayo Clinic, Rochester, MN
11/28/2006 Viral Infections in the Immuncompromised Host – presented by Robin Avery, MD, Cleveland Clinic Foundation, Cleveland, OH
2005
3/15/2005 BMT Through the Eyes of the Coordinator – presented by Sherry Rue, MT, CHTC, National Marrow Donor Program, Minneapolis, MN and Jennifer Wilder, RN, UCSD Bone Marrow Transplant Program, San Diego, CA
3/22/2005 Humoral Immunity – presented by Mark Grebenau, MD, PhD, Novartis Pharmaceuticals, East Hanover, NJ
3/29/2005 Transplanting the Sensitized Patient: Biology versus Pharmacology – presented by Robert Bray, PhD, and Howard Gebel, PhD, Emory University Hospital, Atlanta, GA
4/5/2005 Hero or Villain: The Immune System in BMT – presented by Christopher J. VandenBussche, BS, Georgetown University Medical School, Washington, DC
4/19/2005 TRANS Link 101 – presented by Laurie Olesen, RN, CHTC, National Marrow Donor Program, Minneapolis, MN
5/10/2005 The Pharmacogenetics of Immunosuppression – presented by Mark Grebenau, MD, PhD, Novartis Pharmaceuticals, East Hanover, NJ
5/17/2005 Innovative Approaches for Haploidentical Stem Cell Transplant in Children – presented by Rupert Handgretinger, MD, PhD, Stem Cell Transplant and Gene Therapy Program, St Jude Children’s Research Hospital, Memphis, TN
6/21/2005 Future Challenges in Therapeutic Strategies for Transplantation – presented by Allan Kirk, MD, PhD, Transplantation Branch, NIDDK, National Institutes of Health, Bethesda, MD
6/28/2005 Mechanisms of Anti-HLA Antibody Mediated Graft Damage – presented by Elaine Reed, PhD, UCLA Immunogenetics Center, Los Angeles, CA
7/12/2005 C4d Deposition: An Important Marker of Humoral Rejection – presented by Susan Saidman, PhD, and A. Bernard Collins, PhD, Department of Pathology, Massachusetts General Hospital, Boston, MA
7/26/2005 Creative Laboratory Management: The Next Level – presented by John Hart, MBA, CHS, Johns Hopkins University, Baltimore, MD
8/2/2005 Future Challenges in Clinical Laboratory Support for Transplantation – presented by Peter Nickerson, MD, Canadian Blood Services, Winnipeg, MB, Canada
8/16/2005 Ethical Dilemmas of Organ Transplantation in the 21st Century – presented by Mark Fox, MD, PhD, Oklahoma Bioethics Center, University of Oklahoma College of Medicine, Tulsa, OK
8/23/2005 Effective Time Management in the Workplace – presented by Steward Hickman, SPHR, The Learning Network, Georgetown University Hospital, Washington, DC
9/1/2005 The Clinical Relevance of Donor Specific HLA Antibody in BMT – presented by Claudio Anasetti, MD, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9/13/2005 Things Everyone Should Know About Human Protection and Consent – presented by Roberta King, MPH, Research Support Services, National Marrow Donor Program, Minneapolis, MN
9/20/2005 OPTN/UNOS – presented by Walter Graham, Executive Director, United Network for Organ Sharing, Richmond, VA
9/27/2005 KIR Genotyping for BMT Transplantation – presented by Vicky Turner, PhD, St Jude Children’s Research Hospital, Memphis, TN
10/4/2005 Emerging Infectious Diseases and Their Implications to Transplantation – presented by Chatchada Karanes, MD, National Marrow Donor Program, Minneapolis, MN
11/15/2005 Donor Search Strategies III: More Case Studies – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
2004
3/2/2004 Transplant Immunology 101 – presented by Mark Grebenau, MD, PhD, Director of Medical Information for Transplant Immunology, Novartis Pharmaceuticals, East Hanover, NJ
3/16/2004 The Ins and Outs of CPT Codes – presented by Pamela Kimball, PhD, Medical College of Virginia, Richmond, VA, Ronald Kerman, PhD, University of Texas Medical School, Houston, TX and William LeFor, PhD, LifeLink Foundation Inc, Tampa, FL
3/23/2004 An Overview of the Complement System – presented by Norman Kramer, MD, MEDIMMGEN Consultants Inc., Burtonsville , MD
4/6/2004 Recent Advances in Stem Cell Therapy for Autoimmune Disorders – presented by Richard Burt, MD, Northwestern Memorial Hospital, Chicago , IL
4/20/2004 Search Strategies I: Finding the Best Mismatched Donor – presented by Machteld Oudshoorn, PhD, Europdonor Foundation, Leiden, Netherlands
4/27/2004 Improving the Performance Improvement Process – presented by Barbara Parsons, MA, MT, Johns Hopkins Hospital, Baltimore, MD
5/4/2004 Efficient and Effective Assay Validation – presented by Lori Osowski, MS, CHS and Ashley Hurst, MT, CHT, American Red Cross, National HLA Laboratory, Baltimore, MD
5/18/2004 Implementing, Optimizing and Troubleshooting the ELISA Crossmatch – presented by Patrick Adams, MS, CHS, Ohio State University Hospital, Columbus, OH
5/25/2004 Chronic Allograft Rejection: What Is It and Why Is It Such a Problem? – presented by Charles Orosz, PhD, Ohio State University Hospital, Columbus, OH
6/15/2004 Emerging Molecular Technologies – presented by Ena Wang, MD, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD
6/22/2004 Haplotype-Specific Extraction (HSE): An Innovative New Technology – presented by Johannes Dapprich, PhD, Generation Biotech, LLC, Lawrenceville, NJ and Nancy Murphy, BA, GenoVision, Inc., West Chester, PA
6/29/2004 Transplantation: Unique Challenges in Transfusion Medicine – presented by Shealynn Harris, MD, Transfusion Medicine Service, Department of Pathology, Emory University Hospital, Atlanta, GA
7/13/2004 Post Transplant Antibody Testing – presented by Elaine Reed, PhD, UCLA Immunogenetics Center, Los Angeles, CA
7/27/2004 Demystifying the NMDP – presented by Michelle Setterholm, MT, National Marrow Donor Program, Minneapolis, MN
8/3/2004 Antigen Presentation – presented by Mark Grebenau, MD, PhD, Director of Medical Information for Transplant Immunology, Novartis Pharmaceuticals, East Hanover, NJ
8/10/2004 Implementing, Optimizing, and Troubleshooting the B Cell Crossmatch – presented by Cathi Murphey, MT, CHS, Southwest Immunodiagnostics Inc., San Antonio , TX
9/21/2004 Tumor Vaccines: What are They and How are They Made? – presented by Francesco Marincola, MD, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, MD
10/26/2004 Search Strategies II: Case Studies – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington , DC
11/16/2004 The Role of Alloantibody in Kidney Transplant Deterioration – presented by Philip Halloran, MD, PhD, Director, Division of Nephrology and Immunology, University of Alberta, Edmonton, AB, Canada
2003
2/13/2003 Conceptual Foundations of Immune Recognition – presented by Neil Greenspan, MD, PhD, Case Western Reserve University, Cleveland, OH
2/27/2003 The Logic of Immune Responsiveness – presented by Neil Greenspan, MD, PhD, Case Western Reserve University, Cleveland, OH
3/27/2003 HLA for Beginners – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington , DC
4/3/2003 An HLA Nomenclature Update for 2003 – presented by Ekkehard Albert, PhD, Ludwig Maximilian University, Munich, Germany
4/17/2003 Non-Myeloablative Hematopoietic Stem Cell Transplant: Theory and Practice – presented by Marcos de Lima, MD, M.D. Anderson Cancer Center, Houston, TX
4/24/2003 Donor Search Strategies: A Systematic Approach – presented by Linda Edwins, CHS, Clearwater, FL and Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
5/8/2003 DNA for Beginners – presented by Carolyn Hurley, PhD, Georgetown University and the C.W. Bill Young Marrow Donor Program, Washington, DC
5/15/2003 Back to the Basics: Understanding, Optimizing and Troubleshooting AHG-CDC Assays – presented by Ann Fuller, CHS, University of Utah, Salt Lake City, Utah
5/22/2003 The ELISPOT Assay: What is it and How Can It Be Useful in Transplantation? – presented by Anat Tambur, DMD, PhD, Rush Presbyterian St. Luke’s Medical Center, Chicago, IL
7/17/2003 KIR: What are they? How does one KIR “Type?” How Might KIR Play an Important Role in Transplantation Outcome? – presented by Katharine Hsu, PhD, Memorial Sloan Kettering Cancer Center, New York, NY
7/31/2003 Cord Blood as a Source of Stem Cells for Transplantation – presented by Lee Ann Baxter-Lowe, PhD, University of California, San Francisco, San Francisco, CA
8/14/2003 Transfusion Related Acute Lung Injury (TRALI) – presented by Susan Roseff, MD, Virginia Commonwealth University School of Medicine, Richmond, VA
9/18/2003 Pre-transplant Antibody Testing for Renal Transplantation: A Review of Current Data – presented by Howard Gebel, PhD, Emory University, Atlanta, GA
9/25/2003 HLA Matching Requirements for Hematopoietic Stem Cell Transplantation: A Review of Current Data – presented by Marcelo Fernandez-Vina, PhD, University of Texas, M.D. Anderson Cancer Center, Houston, TX , Victoria Turner, PhD, St. Jude Hospital, Memphis, TN and Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
10/ 9/2003 IvIg Desensitization Protocols: The Laboratories Role – presented by Cathi Murphy, CHS, Southwest Immunodiagnostics, San Antonio, TX, Dolly Tyan, PhD, Cedars-Sinai Medical Center, Los Angeles, CA and Andrea Zachary, PhD, Johns Hopkins University, Baltimore, MD
2002
2/20/2002 Luminex: An Innovative New Technology that Tests Multiple Analytes in a Single Reaction – presented by James Jacobson, PhD, Luminex Corporation, Austin, TX
4/3/2002 HLAMatchmaker – presented by Rene Duquesnoy, PhD, University of Pittsburgh Medical Center, Pittsburgh, PA
4/17/2002 Xenotransplantation: The Promise and the Problems – presented by A. Joseph Tector, MD, Indiana University, Department of Surgery, Indianapolis, IN
5/8/2002 Ethical Considerations in Hematopoietic Stem Cell Transplantation – presented by Jeffrey Kahn, PhD, MPH, University of Minnesota, Center for Bioethics, Minneapolis, MN
7/24/2002 Histocompatibility Testing For Solid Organ Transplantation: Is It Still Important? – presented by Howard Gebel, PhD, Emory University, Atlanta, GA
8/21/2002 VNTR, STR, SNP: What are They? How are They Useful in Transplantation and Immunogenetics? – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
9/4/2002 The Clinical Significance of Flow Cytometric Crossmatching and Antibody Testing – presented by Peter Nickerson, MD, Canadian Blood Services, Winnipeg, MB, Canada
2001
6/13/2001 Immune Suppression: Behind the Scenes, Part I – presented by Robert Bray, PhD, Emory University, Atlanta, GA and Howard Gebel, PhD, Louisiana State University, Shreveport, LA
6/27/2001 Immune Suppression: Behind the Scenes, Part II – presented by Robert Bray, PhD, Emory University, Atlanta, GA and Howard Gebel, PhD, Louisiana State University, Shreveport, LA
8/15/2001 Graft Versus Host Disease – presented by Neal Flomenberg, MD, Thomas Jefferson University, Philadelphia, PA
2000
1/19/2000 Beyond HLA-A, -B and -DR – presented by Carolyn Hurley, PhD, Georgetown University Medical Center, Washington, DC
2/9/2000 Reconciliation of Serologic Type to DNA – presented by Sandra Rosen-Bronson, PhD, Georgetown University Hospital, Washington, DC
1999
4/14/1999 How to Optimize and Interpret Flow Cytometric PRA Assays – presented by Robert Bray, PhD, Emory University, Atlanta, GA and Howard Gebel, PhD, Louisiana State University, Shreveport, LA